 JERSEY CITY, N.J., March 2, 2021 PRNewswire -- WallachBeth Capital, a leading provider of capital markets and institutional execution services, announced the completion of a Registered Direct Offering for Lixte Biotechnology Holdings, Inc. Nasdaq: LIXT, a clinical-stage drug discovery... 